Development and Multicenter Validation of a Novel Immune-Inflammation-Based Nomogram to Predict Survival in Western Resectable Gastric and Gastroesophageal Junction Adenocarcinoma (GEA): The NOMOGAST.
Salati M, De Ruvo N, Giglio MC, Sorrentino L, Esposito G, Fenocchi S, Cucciarrè G, Serra F, Rossi EG, Vittimberga G, Radi G, Solaini L, Morgagni P, Grizzi G, Ratti M, Gelsomino F, Spallanzani A, Ghidini M, Ercolani G, Dominici M, Gelmini R.
Salati M, et al. Among authors: fenocchi s.
J Clin Med. 2022 Sep 16;11(18):5439. doi: 10.3390/jcm11185439.
J Clin Med. 2022.
PMID: 36143086
Free PMC article.